Kaas Sels News Today

Consolidated interim report for the 3 month-period ended 31 March 2024 Pharma Equity Group A/S Slotsmarken 18, 2.,...

     The Board of Directors decision to issue convertible loans   16 May 2024Company Announcement no. 18   The Board of Directors of Pharma Equity Group...

     The Board of Directors decision to issue convertible loans ...

5 April 2024 Company Announcement No. 11 Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s...

Danish English ...

25 March 2024 Announcement no. 10 Notice convening the annual general meeting in Pharma Equity Group A/S The board of directors hereby convenes the annual general meeting in Pharma...

7 February 2024 Company Announcement No. 05 Completion of subscription of convertible loans On 7 February 2024 the Board of Directors in Pharma...

25 January 2024 Company Announcement No. 03 Completion of subscription of convertible loans On 22 January 2024 the Board of Directors in Pharma Equity Group decided to issue convertible...

Pharma Equity Groups subsidiary has received notification from the European Patent Office regarding the decision to grant their patent for drug compositions aiming to eliminate bacterial promoters...

November 28, 2023 Company Announcement no. 46 Status of the companys receivable from Portinho S.A. The Companys Board of Directors, which was elected in connection with the...